Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-content screening of organoids reveals the mechanisms of human pancreas acinar specification.

Cell stem cell·2026
Same author

Inhibition of TGF-beta signaling protects from alpha-synuclein induced toxicity.

Cell death discovery·2025
Same author

Small-molecule dissolution of stress granules by redox modulation benefits ALS models.

Nature chemical biology·2025
Same author

Human organoids with an autologous tissue-resident immune compartment.

Nature·2024
Same author

Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood-retinal barrier-on-a-chip.

Nature communications·2024
Same author

Statistical integration of multi-omics and drug screening data from cell lines.

PLoS computational biology·2024
Same journal

Filibuvir, a non-nucleoside NS5B polymerase inhibitor for the potential oral treatment of chronic HCV infection.

IDrugs : the investigational drugs journal·2010
Same journal

Remimazolam, a short-acting GABA(A) receptor agonist for intravenous sedation and/or anesthesia in day-case surgical and non-surgical procedures.

IDrugs : the investigational drugs journal·2010
Same journal

LX-1031, a tryptophan 5-hydroxylase inhibitor that reduces 5-HT levels for the potential treatment of irritable bowel syndrome.

IDrugs : the investigational drugs journal·2010
Same journal

Dexpramipexole, the R(+) enantiomer of pramipexole, for the potential treatment of amyotrophic lateral sclerosis.

IDrugs : the investigational drugs journal·2010
Same journal

Lu-AA21004, a multimodal serotonergic agent, for the potential treatment of depression and anxiety.

IDrugs : the investigational drugs journal·2010
Same journal

Florbetapir (18F), a PET imaging agent that binds to amyloid plaques for the potential detection of Alzheimer's disease.

IDrugs : the investigational drugs journal·2010
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

High-content screening: a new primary screening tool?

Marc Bickle1

  • 1Max Planck Institute of Molecular Cell Biology and Genetics, Pfotenhauerstrasse 108, D-01307, Dresden, Germany. bickle@mpi-cbg.de

Idrugs : the Investigational Drugs Journal
|November 7, 2008
PubMed
Summary
This summary is machine-generated.

High-content screening (HCS) and high-content analysis (HCA) offer advanced imaging solutions for drug discovery. These technologies are increasingly vital for target identification, screening, and ADMET studies in pharmaceutical research.

More Related Videos

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Related Experiment Videos

Last Updated: Jun 28, 2026

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)
11:38

High Content Screening Analysis to Evaluate the Toxicological Effects of Harmful and Potentially Harmful Constituents (HPHC)

Published on: May 10, 2016

High Content Screening in Neurodegenerative Diseases
13:32

High Content Screening in Neurodegenerative Diseases

Published on: January 6, 2012

Area of Science:

  • Pharmacology
  • Biotechnology
  • Drug Discovery

Background:

  • The pharmaceutical industry faces challenges with low drug success rates and large combinatorial chemical libraries.
  • High-content screening (HCS) and imaging technologies are gaining prominence as alternative methodologies.
  • Current applications of imaging technologies are primarily in pre- and post-primary screening stages.

Purpose of the Study:

  • To review high-content analysis (HCA) technology and methodology.
  • To discuss the role and future potential of HCA in drug discovery.
  • To highlight the increasing importance of imaging in pharmaceutical research.

Main Methods:

  • Discussion of high-content analysis (HCA) principles and techniques.
  • Exploration of various imaging and labeling technologies (fluorescence, luminescence, PET, CT).
  • Review of HCA applications in target identification, validation, secondary screening, ADMET, and pharmacokinetic studies.

Main Results:

  • HCS and HCA are valuable tools for analyzing large chemical libraries.
  • Imaging technologies are integral to various stages of drug development beyond primary screening.
  • Diverse labeling technologies support advanced imaging in pharmaceutical research.

Conclusions:

  • High-content analysis (HCA) represents a significant advancement in drug discovery methodologies.
  • The integration of HCS and HCA is projected to increase, enhancing efficiency and success rates.
  • Future potential of HCA lies in its comprehensive application across the drug development pipeline.